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INTRODUCTION 
The important phenomenon in pharmaceutical formulation 
is “solubility” which plays very effective and significant 
role in the formulation of various dosage forms. Solubility 
of a compound in a particular solvent is defined as the 
concentration of a solute in a saturated solution at a 
certain temperature.1  
The solubility of a drug molecule may be critical factor 
determining its usefulness since the solubility dictates the 
amount of compound that will dissolve and therefore the 
amount available for absorption. If a compound has low 
water solubility it may be subject to dissolution rate 
limited absorption within the gastrointestinal residence 
time. In biopharmaceutical terms the solubility importance 
has been highlighted by Biopharmaceutical Classification 
System (BCS) described by Amidon in 1995 which 
classified the drugs into the four groups as shown in 
Table1.2 
The key parameters on which BCS of a drug depends 
upon are solubility and permeability, solubility play an 
important role for the absorption of drugs.3  
Table 1: The Biopharmaceutical classification system for drugs 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXPRESSING SOLUBILITY AND CONCENTRATION
 
The Solubility is usually expressed by variety of concentration that is by Quantity per quantity, Percentage, Parts, Molarity, 
Molality, Mole fraction, Milliequivalents and normal solutions.5 This is also explained in term of parts of solvent required 
for 1 part of solute as explained in U. S pharmacopeia which is shown in Table 2.  
                      CLASS 1 
High Solubility 
High Permeability  
(Rapid Dissolution For Biowaiver) 
Ex.  Acetoaminophen, Acyclovir, Glucose Antipyrine, 
Buspirone, Diazepam.  
                        CLASS 2 
Low Solubility 
High Permeability 
Ex. Dapsone, Glipizide, Carvedilol, 
Amiodarone, Indinavir, Flurbiprofen. 
 
Absorption Patttern:Well absorbed Absorption Pattern:Variable 
                   CLASS 3 
High Solubility 
Low Permeability 
Ex. Amoxycillin, Cetrizine, Dicloxacillin, Cloxacillin, 
Famotidine.  
                       CLASS 4 
Low Solubility 
Low Permeability 
Ex. AmphotericinB, Colistin, Furosamide, 
Mebendazole, Neomycin. 
Absorption Patttern:Variable Absorption Patttern: Poor 
                      CLASS 1 
High Solubility 
High Permeability  
(Rapid Dissolution For Biowaiver) 
Ex.  Acetoaminophen, Acyclovir, Glucose Antipyrine, 
Buspirone, Diazepam.  
                        CLASS 2 
Low Solubility 
High Permeability 
Ex. Dapsone, Glipizide, Carvedilol, 
Amiodarone, Indinavir, Flurbiprofen. 
 
            SOLUBILITY 
ABSTRACT 
The effectiveness of formulation depends particularly on how efficiently is drug available at the site of action. Therapeutic 
effectiveness of a drug basically depends upon bioavailability and the solubility of drug moiety. Most of the chemical entities 
that are being discovered are lipophilic and have poor aqueous solubility. A more than 40% drug suffers from poor water 
solubility. Currently number of techniques addressed the enhancement of solubility and dissolution rate of poorly soluble 
drugs. Hydrotropic solubilization is one of them. Hydrotropy is a solubilization phenomenon whereby addition of large 
amounts of a second solute results in an increase in the aqueous solubility of another solute. A hydrotrope is a compound that 
solubilises hydrophobic compounds in aqueous solution. To solubilize water insoluble drugs especially in case of oral 
formulation, solubility remains a critical factor so for in this review various solubility enhancement techniques are 
highlighted and a brief review of hydrotropy and its preparation are discussed.  
Keywords: Solubility, Hydrotropy, Mixed hydrotropy 
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Table 2:  Examples of drugs with their solubility 6, 7, 8, 9 
Terms Parts of solvent required for 1 part of solute Examples of drugs 
Very soluble Less than 1parts Metoprolol,  Deltiazam 
Freely  soluble From 1-10 parts Ipratropium bromide 
Soluble From 10-30 parts 
Cyclophosphamide, carmustine, Quinidine, 
Procainamide, Propananolol, Timolol 
Sparingly soluble From 30-100 parts 
Fluorouracil, Quinidine Sulphate, Labetolol, 
Ramipril 
Slightly soluble From 100-1000 parts Fludrabine, Atenolol, Valsartan 
Very slightly soluble From 1000-10,000 parts Busulphan, lomustine, Flecainide, Doxazocine 
Practically Insoluble More than 10,000 parts 
Chlorambucil, Melphlan, Lidocaine, 
Candesartan, Irbesartan, Nifedipine 
 
SOLUBILITY ENHANCEMENT TECHNIQUES 
NANONIZATION
10  
It is a technique where a drug particle is converted into 
nanocrystals having size range of 200-600nm. Pearl 
milling, homogenization in water, homogenization in non 
aqueous media is currently used technologies for 
preparing nanocrystals. 
SUPERCRITICAL FLUID RECRYSTALLIZATION 
(SCF) 10 
Those fluids are referred to as supercritical fluids which 
are having temperature and pressure greater than its 
critical temperature and critical pressure so as they are 
acquire properties of both gas and liquid. The best 
example of this is carbon dioxide. SCF are highly 
compressible at critical temperatures and allows alteration 
in density and mass transport characteristics which 
determines its solvent power due to moderate changes in 
pressure. As the drug gets solubilized within SCF they can 
be recrystallized with reduced particle size of drug.  
USE OF SURFACTANTS
11 
To enhance both permeability of drug and dissolution, the 
surfactants are used as absorption enhancers which fulfills 
the above criteria. The proposed mechanism is that the 
wetting is first primarily promoted and further there is 
penetration of dissolution fluid into solid drug particles. 
Solubility enhancement of poorly water soluble 
antimicrobial drug, enrofloxacin has been studied using a 
series of surfactants and co-solvents.  Among the 
surfactants, ionic surfactants were preferred over the non 
ionic surfactants as they were better solubilizing agents. In 
case of anionic surfactants they possess highest solubility 
rates, considering example of sodium dodecyl sulphate 
which is an anionic surfactant was a better solubilizing 
agent than cetyltrimethyl ammonium bromide which is a 
cationic surfactant.  
EVAPORATIVE PRECIPITATION
12 
In this technique there is a rapid phase separation for 
nucleation and growth of microparticles and nanoparticles 
of water insoluble drugs. In this low boiling solvent is 
selected and a suitable amount of drug is added to it and 
the resultant solution is passed and pumped through a inert 
tube which is heated to a temperature under pressure 
above the selected organic solvent boiling point and 
sprayed into the heated aqueous solution through a fine 
atomizing nozzle. Further the surfactants are added so as 
to optimize the particle size.  
MICRONIZATION
13 
This process typically emphasize on the reduction of drug 
particle size so as to increase in surface area which 
directly enhances dissolution characteristics and 
bioavailability of drug. The size range of drug particles 
after this process is 1-10 microns. The commonly used 
methods are spray drying and fluid energy or jet mill (by 
attrition methods). 
SONOCRYSTALLISATION
13
  
This technique is successfully employed to reduce particle 
size by using ultrasound, is                sonocrystallisation 
which is a novel approach by use of anti-solvents and 
liquid solvents. By adding these anti-solvents and liquid 
solvents, recrystalllization of poorly water soluble drugs 
occurs. 
HIGH PRESSURE HOMOGENIZATION
13
 
It is basically involves the use of high pressure with very 
high velocity by passing the crystalline drug aqueous 
dispersion through a narrow gap. The proposed 
mechanism for this process is by shear forces and 
cavitations due to which particles get disintegrated. In this 
homogenization process drug particle which are obtained 
is dependent on directly pressure, nature of drug substance 
and number of homogenization cycles undergone. It can 
be performed in two ways: either in water (that is in disso 
cubes) or in water reduced media (nanopure). 
NANOMORPH TECHNOLOGY (NT)
 13
 
By use of NT low water soluble drug substances are 
converted into amorphous nanomorph from crystalline 
state. In this suspension of drug substance is prepared in a 
solvent which is mixed with other solvent in a chamber, 
due to this a conversion of drug suspension into a true 
molecular solution occur. Precipitation of drug substance 
is induced by the aqueous solution of polymer. These 
polymers play an important role in preventing of 
aggregation or growth and maintain their nanoparticulate 
state. The example is CAP, Calcium-phosphate based 
nanoparticles which improve the oral bioavailability of 
hormones and proteins. 
DRUG DISPERSION IN CARRIERS
14, 15, 16, 17, 18
 
It was first recognized in 1961 that by use of solid 
dispersion, enhanced dissolution and absorption of drug. 
This term typically refers to dispersion in an inert carrier 
by addition of active ingredients, which is prepared by 
either solvent method or fusion method or by fusion 
solvent method. The carriers for preparation of solid 
dispersions are hydrophilic in nature and generally used 
Poly Vinyl Pyrrolidine, Poloxamer 188, Polyethylene 
Glycol, Plasdone–S630 and sugar carriers such as lactose, 
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sucrose and mannitol. Sometimes surfactants are also used 
such as Tween-80, Docusate sodium etc. The solubility of 
etoricoxib, allopurinol, meloxicam, olanzapine, 
Carbamazepine can be improved by solid dispersion using 
suitable hydrophilic carriers like  etoricoxib with different 
sugar carriers, allopurinol with polyvinylpyrrolidone 
(PVP) K30, PVP K90 and polyethylene glycol (PEG) 
4000 and PEG 6000, meloxicam with Poloxamer 188, 
carbamazepine with  crospovidone and 
hydroxypropylmethylcellulose,  olanzapine with 
pregelatinised starch  and sodium starch glycollate.  
BY USE OF CO-SOLVENTS
19 
By addition of co-solvents, solubility of poorly water 
soluble drugs can be improved. There is a dramatic 
change in the solubility of drugs by addition of organic 
co-solvent into the water. The co-solvents are having 
hydrogen acceptor or donor groups with a small 
hydrocarbon region. The hydrophobic hydrocarbon region 
usually interferes with the hydrogen bonding network of 
water which consequently reduces the intermolecular 
attraction of water while the hydrophilic hydrogen bonds 
ensures water solubility. 
CHEMICAL MODIFICATIONS
20
 
For increasing the aqueous solubility of poorly water 
soluble drugs, change in pH of a system is the simplest 
and most effective method. There is an exponential 
increase in the solubility of ionizable drug by changing the 
pH of solution. The drug which is to be efficiently 
solubilised should be a weak base with a high pKa value 
or weak acid with a low pKa value. The use of salt forms 
is a well known technique to enhanced dissolution 
profiles. Salt formation is the most common and effective 
method of increasing solubility and dissolution rates of 
acidic and basic drugs.  
CRYSTAL HABIT MODIFICATION
20
 
The property of a compound to exhibit in more than 
crystalline form is referred to as polymorphism. It is 
observed that they exhibit different physiochemical 
property such as stability, melting point, density etc. but 
are identical chemically. 
MOLECULAR ENCAPSULATION WITH 
CYCLODEXTRINS
21
 
The unique property of cyclodextrins and their derivative 
is their ability to form molecular inclusion complexes with 
poorly water soluble drugs. These are usually having a 
hydrophobic cavity having enough space to accommodate 
“guest” molecules which are lipophilic in nature and 
oligosaccharide shaped bucket to hold this cavity. Thus 
the drugs get encapsulated in the cavity and results in 
improved aqueous solubility and enhance dissolution 
rates. Barbiturates and NSAIDS are examples with 
enhanced bioavailability. 
HYDROTROPIC SOLUBILISATION  
It is a technique firstly introduced by Neuberg (1916).20, 22 
It is a process where large amount of secondary solute 
added and as a results increased aqueous solubility of 
water insoluble drugs. 
 MECHANISM OF ACTION OF HYDROTROPE 
Neubergs conventional hydrotropic salts generally consist 
of two parts, a hydrophobic aromatic ring or ring system 
and anionic group. The prerequisite for a hydrotropic 
substance is anionic group which is responsible for 
bringing high aqueous solubility. There is a minor effect 
on the type of anion or metal ion. On the flip side 
planarity of hydrophobic part also plays a crucial role in 
hydrotropic solubilisation mechanism.23 Those salts or 
additives which increases solubility in a given solvent are 
referred to as “salt in” and which decreases solubility are 
referred to as “salt out”. Hydrotropism refers to as salting 
in of non electrolytes which are highly soluble in water. 
The mechanism involved in hydrotropy is related to 
complexation which involves interaction between 
lipophilic drugs and the hydrotropic agents such as urea, 
nicotinamide, sodium alginate, sodium benzoate etc.22 
ADVANTAGES OF HYDROTROPIC 
SOLUBILISATION  
 This process doesn’t require emulsification, highly 
selective and solvent character is independent of pH so 
it is preferred over other solubilisation methods such 
as cosolvency, micellar solubilisation. 
 It primarily involves the mixing of hydrotrope and 
drug directly into solvent which is water. 
 It precludes the chemical modification of hydrophobic 
drugs or preparation of emulsion system. 
Hydrotropes are having the ability to increase the 
solubility of poorly water soluble drug and this tendency 
is greatest when concentration of hydrotropes is 
sufficiently enough to form the associated structures. 
Minimum hydrotrope concentration is referred to 
concentration of hydrotrope at which self association 
occurs. Hydrotrope can be categorized according to their 
structure as shown in Table 3. 
METHOD OF PREPARATION OF HYDROTROPIC 
SOLID DISPERSION 
It is a relatively new technique in which the drug and 
selected hydrotropes are taken in different ratio in beaker, 
distilled water is added at a temperature ranging between 
80-85°C. Then the selected hydrotrope is taken and added 
to water. Then slowly add drug to the beaker and teflon 
coated magnetic bead is dropped in beaker, temperature is 
to be maintained for optimum stirring and stirring is 
continued until semisolid mass is obtained. This semisolid 
mass is spread on several watch glasses and is placed in 
oven maintaining a temperature of 60-65°C. Then the 
trituration is done with pestle and mortar and after drying 
passes it through sieve no.100 and kept in desiccators for 
6 days. Flow chart 1.25, 26  
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Table 3: Classification of Hydrotropes24 
Category Examples Structure 
Aromatic anionics 
Sodium benzoate 
COO-Na+
 
Sodium salicylate 
COO-Na+
OH  
Sodium benzene sulphonate 
SO3
-Na+
 
Sodium benzene disulphonate 
SO3
-Na+
SO3
-Na+  
Sodium cinnamate 
CH CH COO
-Na+
 
Sodium3-hydroxy-2-naphthoate 
COO-Na+
OH  
Sodium para toluene sulphonate. 
H3C
SO3
-Na+
 
Sodium cumene sulphonate 
SO3
-Na+
CH
H3C
CH3  
Aromatic cationics 
Para amino benzoic acid hydrochloride 
COOH
NH3
+Cl-  
Procaine hydrochloride 
COOCH2CH2N
NH3
+Cl -
Et
Et
 
Caffeine 
N
N N
NH3C
CH3
CH3
O
 
Aliphatics and linear anionics Sodium alkanoate CH3 (CH2)x COO
-Na+
 
 
Flow Chart1. Preparation of hydrotropic solid dispersion 
                                           Distilled water (80-85°C) 
                                                               Put  Hydrotrope 
                                                     Beaker  
                                                   Dissolve 
 
                                                  Add Drug 
                                                           Stir 
                                            In Magnetic Stirrer 
 
                                      Formation of Semisolid Mass 
                                          Poured on watch  glass 
 
                                          Keep in Oven (60-65°C) 
                                                               To make it pulverizable 
                                        Triturate in pestle    mortar 
                                                             Kept   in oven 
        Drying 
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MIXED HYDROTROPY 
It is a solubilization technique to increase the water 
solubility of poorly water soluble drugs by using different 
ratio of blends of hydrotropic agents which gives 
synergistic enhancement effect. The main advantage of 
this technique is that it reduces the concentration of 
individual hydrotropic agents which directly reduces the 
side effects of individual hydrotropic agent. A novel, safe 
and sensitive method of spectrophotometric determination 
of Hydrochlorothiazide in tablets was developed using 
mixed hydrotropic solubilisation technique and concluded 
that there is enhancement of solubility up to 25 folds by 
mixed hydrotropy. Hydrotropic solid dispersion of 
aceclofenac was formulated and evaluated by using six 
blends of hydrotropes (urea and sodium citrate) and 
concluded that solubility of aceclofenac increases 
synergistically by mixed hydrotropic solublization 
technique.27 
A further study was analyzed by using mixed hydrotropy 
on nitazoxanide, using sodium benzoate and sodium 
salicylate as hydrotropic agents and accomplished that 
there is enhancement of solubility up to 12 folds.28 
Various drugs have been enlisted here whose solubility 
has been enhanced by use of hydrotropes which is 
presented in Table 4. 
 
Table 4: Solubility enhancement of poorly water soluble drugs by using hydrotrope 
Drugs Name Category Hydrotropes Used Solubility Enhancement 
Curcuminoids29 
Natural 
compound(Phenolic) 
Sodium Salicylate, Sodium 
Benzoate, Resorcinol. 
144 times 
Chartreusin30 Cytotoxic agent 
Sodium Benzoate, Sodium 
trihydroxy Benzoate. 
Solubility enhanced. 
Cefadroxil
32
 Antibiotic (Cephalosporin) Urea 10 times 
Glipizide32 Antidiabetic 
SodiumBenzoate, Sodium acetate, 
Sodium salicylate. 
55 times 
Fenofibrate33 Lipid lowering drug Urea, Sodium citrate 233 times 
Aceclofenac34 NSAIDS Urea, Sodium citrate 250 times 
Pramipexole 
Dihydrochloride35 
Antiparkinson Urea, Sodium acetate 
46 times 
 
Pacilitaxel36 Anticancer 
N N Diethyl Nicotinamide, 
N N Dimethyl  Benzamide 
Solubility enhanced. 
Losarton37 Antihypertensive Sodium chloride 63 times 
Simvastatin37 Antihyperlipidemic Sodium chloride 90 
Tenfovir Disoproxil 
Fumerate38 
Antiretroviral Sodium Benzoate 112-121 times 
Metronidazole39 Antiprotozoal Sodium Benzoate 5 times 
Tinidazole39 Antiparasitic Sodium Benzoate 6 times 
Norfloxacin39 Antibiotic Sodium Benzoate 40 times 
Nalidixic acid39 Antibiotic Sodium Benzoate 98 
Ketoprofen40 NSAIDS 
Urea, Sodium Acetate, Sodium 
Citrate 
570 times 
Indomethacin41 NSAIDS Sodium p-hydroxy benzoate 117.5 times 
Amlodipine Besylate42 Antihypertensive Urea 7 times 
Benzoic acid43 Antifungal, Antibacterial Sodium benzoate, Sodium salicylate 
14 fold enhancement with 
sodium benzoate and 28 
fold with sodium salicylate 
Pacilitaxel44 Anticancer Hydrotropic polymer and hydrogel Solubility enhanced 
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